Company intelligence / Profile preview

Index Ventures

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Index Ventures invests in early and growth-stage biotech and life science companies, emphasizing asset-centric models focused on single or few therapeutic assets. Many molecules from labs financed by Index are in late-stage clinical development by pharmaceutical partners.

Modalities: Small moleculeMonoclonal antibodyProteinPeptidesVaccineGene therapyEnzyme replacement therapy
Industry: Investors

Partnerships

GlaxoSmithKlineJanssen (Johnson & Johnson)CradleNovozymesTwist Bioscience

Beyond the preview

Go deeper on Index Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Index Ventures.

Explore the full profile